Prospective association of vitamin D concentrations with mortality in postmenopausal women: Results from the Women's Health Initiative (WHI)

American Journal of Clinical Nutrition

Volumn 94, Issue 6, 2011, Pages 1471-1478

  Eaton, Charles B ^a   Young, Alicia ^c   Allison, Matthew A ^d   Robinson, Jennifer ^e   Martin, Lisa W ^l   Kuller, Lewis H ^f   Johnson, Karen C ^g   Curb, J David ^h   Van Horn, Linda ⁱ   McTiernan, Anne ^b   Liu, Simin ^j   Manson, JoAnn E ^k  

^a BROWN UNIVERSITY   (United States)

^b Public Health Sciences Division   (United States)

^c Fred Hutchinson Cancer Research Center   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e UNIVERSITY OF IOWA   (United States)

^f University Professor of Public Health   (United States)

^g UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^h UNIVERSITY OF HAWAII   (United States)

ⁱ NORTHWESTERN UNIVERSITY   (United States)

^j UNIVERSITY OF CALIFORNIA   (United States)

^k BRIGHAM AND WOMEN S HOSPITAL   (United States)

^l NONE

more..

Author keywords

[No Author keywords available]

Indexed keywords

VITAMIN D;

ABDOMINAL OBESITY; ADULT; AGED; ARTICLE; BODY FAT DISTRIBUTION; CARDIOVASCULAR DISEASE; CAUSE OF DEATH; ETHNICITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MORTALITY; NEOPLASM; OBESITY; POSTMENOPAUSE; PROSPECTIVE STUDY; WAIST CIRCUMFERENCE; WOMEN'S HEALTH;

AGED; BODY FAT DISTRIBUTION; CARDIOVASCULAR DISEASES; CAUSE OF DEATH; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; NEOPLASMS; OBESITY, ABDOMINAL; POSTMENOPAUSE; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; VITAMIN D; VITAMIN D DEFICIENCY; WAIST CIRCUMFERENCE;

EID: 82355188303     PISSN: 00029165     EISSN: 19383207     Source Type: Journal    
DOI: 10.3945/ajcn.111.017715     Document Type: Article

References (30)

1. Heaney RP. Functional indices of vitamin D status and ramifications of vitamin D deficiency. Am J Clin Nutr 2004;80(suppl):1706S-9S.
2. Cauley JA, Lacroix AZ, Wu L, Horwitz M, Danielson ME, Bauer DC, Lee JS, Jackson RD, Robbins JA, Wu C, et al. Serum 25-hydroxyvitamin D concentrations and risk for hip fractures. Ann Intern Med 2008;149: 242-50.
3. Holick MF. Sunlight and vitamin D for bone health and prevention of autoimmune disease, cancers, and cardiovascular disease. Am J Clin Nutr 2004;80(suppl):1678S-88S.
4. Wang TJ, Pencina MJ, Booth SL, Jacques PF, Ingelsson E, Lanier K, Benjamin EJ, D'Agostino RB, Wolf M, Vasan RS. Vitamin D deficiency and risk of cardiovascular disease. Circulation 2008;117: 503-11.
5. Giovannucci E, Liu Y, Rimm EB, Hollis BW, Fuchs CS, Stampfer JM, Willett WC. Prospective study of predictors of vitamin d status and cancer incidence and mortality in men. J Natl Cancer Inst 2006;98: 451-9.
6. Pittas AG, Lau J, Hu FB, Dawason-Hughes B. The role of vitamin D and calcium in type 2 diabetes. A systematic review and meta-analysis. J Clin Endocrinol Metab 2007;92:2017-29. (Pubitemid 46997093)
7. Munger KL, Levin LI, Hollis BW, Howard NS, Ascherio A. Serum 25-hydroxy vitamin D levels and risk of multiple sclerosis. JAMA 2006;296:2832-8. (Pubitemid 44969183)
8. Zasloff M. Fighting infections with vitamin D. Nat Med 2006;12: 388-90.
9. Melamed ML, Michos ED, Post W, Astor B. 25-Hydroxyvitamin D levels and the risk of mortality in the general population. Arch Intern Med 2008;168:1629-37.
10. Dobnig H, Pilz S, Scharnagl H, Renner W, Seelhorst U, Wellnitz B, Kinkeldei J, Boehm BO, Weihrauch G, Maerz W. Independent association of low serum 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D levels with all-cause and cardiovascular mortality. Arch Intern Med 2008;168:1340-9. (Pubitemid 351930842)
11. Ordonez-Moran P, Larriba MJ, Pendas-Franco N, Aguilera O, Gonzalez-Sancho JM, Munoz A. Vitamin D and cancer: an update of in vitro and in vivo data. Front Biosci 2005;10:2723-49. (Pubitemid 40908912)
12. Banerjee P, Chatterjee M. Antiproliferative role of vitamin D and its analogs - a brief overview. Mol Cell Biochem 2003;253:247-54. (Pubitemid 37321732)
13. Liu PT, Stenger S, Li H, Wenzel L, Tan BH, Krutzik SR, Ochoa MT, Schauber J, Wu K, Meinken C, et al. Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response. Science 2006; 311:1770-3.
14. Autier P, Gandini S. Vitamin D Supplementation and total mortality. A meta-analysis of randomized controlled trials. Arch Intern Med 2007; 167:1730-7. (Pubitemid 47403059)
15. LaCroix AZ, Kotchen J, Anderson G, Brzyski R, Cauley JA, Cummings SR, Gass M, Johnson KC, Ko M, Larson J, et al. Calcium plus vitamin D supplementation and mortality in postmenopausal women: the Women's Health Initiative calcium-vitamin D randomized controlled trial. J Gerontol A Biol Sci Med Sci 2009;64:559-67.
16. IOM (Institute of Medicine). 2011 Dietary Reference Intakes for calcium and vitamin D. Washington, DC: National Press Club, 2010.
17. Anderson GL,Manson J,Wallace R, Lund B, Hall D, Davis S, Shumaker S, Wang CY, Stein E, Prentice RL. Implementation of the Women's Health Initiative study design. Ann Epidemiol 2003;13(suppl):S5-17.
18. Hays J, Hunt JR, Hubbell FA, Anderson GL, Limacher M, Allen C, Rossouw JE. The Women's Health Initiative recruitment methods and results. Ann Epidemiol 2003;13(suppl):S18-77. (Pubitemid 37324176)
19. Robinson JG, Manson JE, Larson J, Liu S, Song Y, Howard BV, Phillips L, Shikany JM, Allison M, Curb JD, et al. Lack of association between 25(OH)D levels and incident type 2 diabetes in older women. Diabetes Care 2011;34:628-34.
20. Allison PD. Survival analysis using SAS: a practical guide. Cary, NC: SAS Institute Inc., 1995:158-61.
21. Durrleman S, Simon R. Flexible regression models with cubic splines. Stat Med 1989;8:551-61. (Pubitemid 19116001)
22. Semba RD, Houston DK, Ferrucci L, Cappola AR, Sun K, Guralnik JM, Fried LP. Low serum 25-hydroxyvitamin D concentrations are associated with greater all-cause mortality in older community-dwelling women. Nutr Res 2009;29:525-30.
23. Ginde AA, Scragg R, Schwartz R, Camargo C. Prospective study of serum 25-hydroxyvitamin D level, cardiovascular disease mortality, and all-cause mortality in older U.S. adults. J Am Geriatr Soc 2009;57: 1595-603.
24. Cheng S, Massaro JM, Fox CS, Larson MG, Keyes MJ, McCabe EL, Robins SJ, O'Donnell CD, Hoffmann U, Jacques PF, et al. Adiposity, cardiometabolic risk, and vitamin D status: the Framingham Heart Study. Diabetes 2010;59:242-8.
25. Vashi PG, Lammersfeld C, Braun D, Gupta D. Serum 25-hydroxyvitamin D is inversely associated with body mass index in cancer. Nutr J 2011;10:51.
26. Chacko SA, Song Y, Manson J, Van Horn L, Eaton C, Martin L, McTiernan A, Curb JD, Wylie-Rosett J, Phillips L, et al. Serum 25-hydroxyvitamin concentrations in relation to cardiometabolic risk factors and metabolic syndrome in postmenopausal women. Am J Clin Nutr 2011;94:209-17.
27. Pilz S, Dobnig H, Nijpels G, Heine RJ, Stehouwer CD, Snijder MB, van Dam RM, Dekker JM. Vitamin D and mortality In older men and women. Clin Endocrinol (Oxf) 2009;71:666-72.
28. Kilkkinen A, Knekt P, Aro A, Rissanen H, Marniemi J, Heliövaara M, Impivaara O, Reunanen A. Vitamin D status and the risk of cardiovascular disease death. Am J Epidemiol 2009;170:1032-9.
29. Abnet CC, Chen Y, Chow WH, Gao YT, Helzlsouer KJ, Le Marchand L, McCullough ML, Shikany JM, Virtamo J, Weinstein SJ, et al. Circulating 25-hydroxyvitamin D and risk of esophageal and gastric cancer cohort consortium vitamin d pooling project of rarer cancers. Am J Epidemiol 2010;172:94-106.
30. Yin L, Grandi N, Raum E, Haug U, Arndt V, Brenner H. Meta-analysis: serum vitamin D and breast cancer risk. Eur J Cancer 2010;46:2196-205.